+7 (701) 759 90 19
USD 426.32 EUR 496.24
RUB 6.04 CNY 66.74
News

Why Kazakhstan continues to use hydroxychloroquine to treat COVID-19 patients

23 June 2020 10:56
Share in:
Why Kazakhstan continues to use hydroxychloroquine to treat COVID-19 patients

NUR-SULTAN. KAZINFORM – Kazakhstan's leading infectious disease physician Dinagul Baesheva spoke about why the country hasn’t followed the footsteps of the WHO and the U.S. and continues to treat COVID-19 patients with hydroxychloroquine, Kazinform correspondent reports.

Related news
Kazakhstan’s daily COVID-19 case count stands at 1,732 October 23. Kazinform's timeline of major events G-20 should lead preparation for next pandemic: vaccine alliance chief

Speaking at an online briefing of the Central Communications Service, Baesheva pointed out that the disease (COVID-19) causes different pathogeneses.

According to her, hydroxychloroquine is used in patients depending on the severity of their condition and clinical laboratory specifics. She also mentioned that hydroxychloroquine had been extensively appropriated in some European countries and the U.S. According to her, no fatalities caused by hydroxychloroquine have been reported yet.

She went on to say that given the risks and benefits hydroxychloroquine is used in a COVID-19 patient for five days. She insisted good results had been observed after the treatment with hydroxychloroquine. That is why, in her words, it is included in the medical protocol.



Share in:

Author:

Adlet Seilkhanov

Related news
Read also
+7
Send
Employees online

Archive